Connect your AI

10x Genomics, Inc. TXG Book value per share

Book value per share at other companies

TEC

Bio-TechneTECH

$13.25+4.3%

BrukerBRKR

$16.16+33.9%

IlluminaILMN

$17.38+16.7%

Twist Bioscience CorporationTWST

$7.380.0%

RevvityRVTY

$64.20+1.1%

Bio-Rad LaboratoriesBIO

$254.15+6.4%

Other financials

Income statement

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

total stockholders equity/weighted shares diluted=$6.35

Based on the most recent quarter.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is 10x Genomics, Inc.'s book value per share?: 10x Genomics, Inc. (TXG) reported book value per share of $6.35 in Q1 2026.
How has 10x Genomics, Inc.'s book value per share changed year-over-year?: 10x Genomics, Inc.'s book value per share increased by 10.1% year-over-year, from $5.77 to $6.35.
What is the long-term trend for 10x Genomics, Inc.'s book value per share?: Over 5 years (2020 to 2025), 10x Genomics, Inc.'s book value per share has grown at a -2.7% compound annual growth rate (CAGR), from $7.31 to $6.38.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.